Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates.
about
Experimental Infection of Calves by Two Genetically-Distinct Strains of Rift Valley Fever VirusRift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate.Genetic stability of Rift Valley fever virus MP-12 vaccine during serial passages in culture cells.Rift Valley Fever.Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates.
P2860
Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Rift Valley fever MP-12 vaccin ...... cterization of virus isolates.
@ast
Rift Valley fever MP-12 vaccin ...... cterization of virus isolates.
@en
type
label
Rift Valley fever MP-12 vaccin ...... cterization of virus isolates.
@ast
Rift Valley fever MP-12 vaccin ...... cterization of virus isolates.
@en
prefLabel
Rift Valley fever MP-12 vaccin ...... cterization of virus isolates.
@ast
Rift Valley fever MP-12 vaccin ...... cterization of virus isolates.
@en
P2093
P2860
P1433
P1476
Rift Valley fever MP-12 vaccin ...... acterization of virus isolates
@en
P2093
Barbara A Schibly
Elizabeth S Brown
George E Bettinger
John C Morrill
Lawrence Korman
Manmohan V Ranadive
Nandadeva Lokugamage
Sarah L Norris
P2860
P304
P356
10.1016/J.VACCINE.2015.11.078
P407
P577
2015-12-17T00:00:00Z